When the Sjöberg Foundation recently distributed research grants in the area of difficult-to-treat cancer with a poor prognosis, three of the total of nine grants funded went to projects at Sahlgrenska Academy and Sahlgrenska University Hospital. Jonas Nilsson receives SEK 5 million for his project on CAR-T cell treatment for treatment-resistant skin and uveal melanoma. Göran Stenman receives SEK 3 million for the development of a new targeted treatment for patients with the therapy-resistant and deadly cancer form adenoid cystic cancer. Karin Sundfeldt receives SEK 4 million for the development of a screening tool for ovarian cancer that greatly may reduce mortality from the disease.
Sahlgrenska akademins nyheter
Majority of 15–19-year-olds wanted COVID jab
New occasion: drop-in vaccination on campus on October 29
New, updated edition of “Handbook of Disaster and Emergency Management”
Picture rain from the children’s hospital’s new inauguration
The 2021 Bollan Stipend shared by five young researchers
Young researchers – take the opportunity to coach or be coached
Network improves knowledge about hidden common disease
Low-status jobs with high vulnerability during pandemic
Obesity in four out of ten adults with COVID-19 in intensive care
